Fourteen senators are pushing back against a potential reclassification of potatoes from vegetables to grains by the US Department of Agriculture and Department of Health and Human Services.
Larry David, the creator of “Curb Your Enthusiasm” and “Seinfeld”, expressed his strong disapproval of former President Donald Trump in a recent episode of CNN’s “Who’s Talking to Chris Wallace?”
Former President Donald Trump has initiated a verbal onslaught against the daughter of the judge who will be presiding over his impending criminal trial in New York.
Monster Beverage (NASDAQ:MNST) has outperformed the market over the past 10 years by 6.99% on an annualized basis producing an average annual return of 17.71%. Currently, Monster Beverage has a market capitalization of $62.00 billion.
Arch Capital Group (NASDAQ:ACGL) has outperformed the market over the past 20 years by 8.16% on an annualized basis producing an average annual return of 16.03%. Currently, Arch Capital Group has a market capitalization of $34.59 billion.
Vertiv Hldgs (NYSE:VRT) has outperformed the market over the past 5 years by 39.36% on an annualized basis producing an average annual return of 52.2%. Currently, Vertiv Hldgs has a market capitalization of $31.14 billion.
DateFirmActionFromTo Jan 2022Morgan StanleyMaintainsEqual-Weight Jan 2022Morgan StanleyMaintainsEqual-Weight Jan 2022OppenheimerUpgradesPerformOutperform
Heico (NYSE:HEI) has outperformed the market over the past 15 years by 11.56% on an annualized basis producing an average annual return of 24.51%. Currently, Heico has a market capitalization of $26.43 billion.
Top Stories: GROY reports lower than expected Q4 revenue, USAP sees record sales in Q4 and 2023, ATLX secures $30M investment, XPL discovers high-grade gold zone at Golden Crest project.
ResMed (NYSE:RMD) has outperformed the market over the past 10 years by 5.16% on an annualized basis producing an average annual return of 15.88%. Currently, ResMed has a market capitalization of $29.13 billion.
Partners Beckley Psytech and atai Life Sciences (NASDAQ:ATAI) have jointly announced positive initial results from a Phase 2a study of Beckley's novel formulation of 5-MeO-DMT in Treatment Resistant Depression (TRD.)
There is an ongoing sentiment in the U.S. that if the Midwest accepts new trends, they’ll be accepted across the nation. In the case of cannabis, with Midwest acceptance it will be deemed non-controversial anymore, writes New Frontier’s…
DateFirmActionFromTo Feb 2022Raymond JamesUpgradesOutperformStrong Buy Feb 2022Morgan StanleyMaintainsEqual-Weight Jan 2022KeybancInitiates Coverage OnSector Weight